Sec. 597.052. SCOPE OF CONSENT. (a) The committee or the surrogate decision-maker may consent to the release of records related to the client's condition or treatment to facilitate treatment to which the committee or surrogate decision-maker has consented.
(b) The interdisciplinary team may consent to psychoactive medication subsequent to the initial consent for administration of psychoactive medication made by a surrogate consent committee in accordance with rules of the department until the expiration date of the consent.
(c) Unless another decision-making mechanism is provided for by law, a client, a client's authorized surrogate decision-maker if available, or the client's interdisciplinary team may consent to decisions which involve risk to client protection and rights not specifically reserved to surrogate decision-makers or surrogate consent committees.
Added by Acts 1993, 73rd Leg., ch. 530, Sec. 1, eff. Aug. 30, 1993. Amended by Acts 1997, 75th Leg., ch. 450, Sec. 8, eff. Sept. 1, 1997. Reenacted by Acts 1999, 76th Leg., ch. 538, Sec. 1, eff. June 18, 1999.
Structure Texas Statutes
Title 7 - Mental Health and Intellectual Disability
Subtitle D - Persons With an Intellectual Disability Act
Chapter 597 - Capacity of Clients to Consent to Treatment
Subchapter C. Surrogate Consent for Icf-Iid Clients
Section 597.041. Surrogate Decision-Makers
Section 597.042. Surrogate Consent Committee Established; Departmental Support
Section 597.043. Committee Membership
Section 597.044. Application for Treatment Decision
Section 597.045. Notice of Review of Application for Treatment Decision
Section 597.046. Prereview of Application
Section 597.047. Confidential Information
Section 597.048. Review of Application
Section 597.049. Determination of Best Interest
Section 597.050. Notice of Determination
Section 597.051. Effect of Committee's Determination